Product Highlight - Etoricoxib (Ebicox)
13 Sep 2024
Life Back in MOTION
Ebicox is a selective COX-2 inhibitor recommended in adults and adolescents 16 years and above for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), and ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis.2,3
For the short-term treatment of moderate pain associated with dental surgery.1,2,3
Usual Recommended Dose: Osteoarthritis: 30-60 mg tablet daily; Rheumatoid arthritis: 60-90 mg tablet daily; Ankylosing spondylitis: 60-90 mg tablet daily; Acute gouty arthritis: 120 mg tablet daily; Post-operative dental surgery pain: 90 mg tablet daily.1
REFERENCES:
1. Full prescribing information of Ebicox.
2. Collantes-Estevez et al: Rapid onset of analgesic effect (at 24 minutes). (Future Rheumatol.(2007) 2 (6) 553. Profound COX-2 Inhibition up to 24 hours (convenient once-daily dosing regimen) (Future Rheumatol.(2007) 2 (6) 548
3. Brooks, P., & Kubler, P. (2006). Etoricoxib for arthritis and pain management. Therapeutics and clinical risk management, 2(1), 45–57.
THE CATHAY DRUG COMPANY, INC.
2/F Vernida I Condominium, 120 Amorsolo St.,
Legaspi Village, Makati City
Website: www.cathaydrug.ph
Ebicox is a selective COX-2 inhibitor recommended in adults and adolescents 16 years and above for the symptomatic relief of osteoarthritis (OA), rheumatoid arthritis (RA), and ankylosing spondylitis, and the pain and signs of inflammation associated with acute gouty arthritis.2,3
For the short-term treatment of moderate pain associated with dental surgery.1,2,3
Usual Recommended Dose: Osteoarthritis: 30-60 mg tablet daily; Rheumatoid arthritis: 60-90 mg tablet daily; Ankylosing spondylitis: 60-90 mg tablet daily; Acute gouty arthritis: 120 mg tablet daily; Post-operative dental surgery pain: 90 mg tablet daily.1
REFERENCES:
1. Full prescribing information of Ebicox.
2. Collantes-Estevez et al: Rapid onset of analgesic effect (at 24 minutes). (Future Rheumatol.(2007) 2 (6) 553. Profound COX-2 Inhibition up to 24 hours (convenient once-daily dosing regimen) (Future Rheumatol.(2007) 2 (6) 548
3. Brooks, P., & Kubler, P. (2006). Etoricoxib for arthritis and pain management. Therapeutics and clinical risk management, 2(1), 45–57.
THE CATHAY DRUG COMPANY, INC.
2/F Vernida I Condominium, 120 Amorsolo St.,
Legaspi Village, Makati City
Website: www.cathaydrug.ph
